Pfizer seeks to roll out coronavirus vaccine starting this fall
Pfizer, the pharmaceutical giant with a research and development center in Pearl River, is looking to roll out a coronavirus vaccine on high-risk groups in the fall -- and expand it to a larger population sometime in 2021.
•
May 8, 2020, 9:27 PM
•
Updated 1,583 days ago
Share:
Pfizer, the pharmaceutical giant with a research and development center in Pearl River, is looking to roll out a coronavirus vaccine on high-risk groups in the fall -- and expand it to a larger population sometime in 2021.
Vice President Phil Dormitzer says right now, clinical trials are underway, with four different potential vaccines.
Last month, trials began in Europe with about 200 people. This month in the U.S., about 360 people were part of the trial. All participants were between 18 and 55 years old and had a clean bill of health.
Once they received their dose, they are not inundated or purposely exposed to the virus - they are encouraged to do the opposite.
It will take some time before Pfizer can find a secure option, due to so many variables.
Dormitzer says that although they are working quickly, they are working extremely carefully and not skipping anything along the way.
Currently, U.S. trials are taking place at NYU's Grossman School of Medicine and University of Maryland's School of Medicine.
Vice President Phil Dormitzer says right now, clinical trials are underway, with four different potential vaccines.
Last month, trials began in Europe with about 200 people. This month in the U.S., about 360 people were part of the trial. All participants were between 18 and 55 years old and had a clean bill of health.
Once they received their dose, they are not inundated or purposely exposed to the virus - they are encouraged to do the opposite.
It will take some time before Pfizer can find a secure option, due to so many variables.
Dormitzer says that although they are working quickly, they are working extremely carefully and not skipping anything along the way.
Currently, U.S. trials are taking place at NYU's Grossman School of Medicine and University of Maryland's School of Medicine.
More from News 12
2:09
Emergency sewer repair project in Greenburgh stinks – but it’s necessary, officials say
1:57
Chilly morning, pleasant afternoon Sunday in the Hudson Valley
1:58
Residents learn more about $12.9M facelift proposal for Nanuet Public Library
0:48
Rain doesn't damper celebration at 13th annual Italian Feast and Festival in Tappan
0:53
Nearly $2 million to fund intelligence center, body cameras for Orange County law enforcement
2:00
